https://charts.traderzeitung.de/phases/US74340E1038 string(1409) "{"isin":"US74340E1038","name":"Progyny Inc","stock_id_xnas":10283715,"stock_id_xnys":10283713,"generated_at":"2026-07-18 04:21:00","days":[{"date":"2026-07-15","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":32.32,"close_at":"2026-07-15 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":33,"close_at":"2026-07-16 12:12:00","complete":true,"perf_pct":2.104},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":31.88,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":-3.3939},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":31.94,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":0.1882},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

Progyny Aktie News & Nachrichten

[WKN: A2PT5Q | Symbol: PGNY]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

13.05.2026 um 14 Uhr

Progyny

Progyny: Der stille Gewinner des Trends zu später Familienplanung

Progyny ist ein US-amerikanischer Anbieter von Fruchtbarkeits- und Familienplanungsleistungen für Unternehmen...

Progyny Nachrichtenticker öffnen

MT Newswires 22.06.2026 12:53 Uhr

Truist passt Kursziel für Progyny auf 33 $ von 30 $ an, behält Kaufempfehlung bei

06:52 AM EDT, 06/22/2026 (MT Newswires) -- Progyny (PGNY) hat eine durchschnittliche Kaufempfehlung und ein mittleres Kursziel von 30 $, laut von Fact